Businesses

3D4Medical

3D4Medical is an award winning technology company that specialises in the development of medical, educational and health & fitness apps for professional reference as well as student and patient education.

Company website

Recent company news

June 8, 2017

3D4Medical announces exclusive partnership with Sky

Altan Pharma

Altan is a global injectable drug company headquartered in Dublin, Ireland and committed to improving patient care by providing specialty medications of superior quality and value for the benefit of patients and caregivers.

Company website

Recent company news

April 17, 2018

Altan Pharma Announces the Grant of Two Patents by the USPTO

AN2H Discovery

AN2H is an Irish headquartered company focused on designing novel small molecule therapeutics that target key proteins within the Ubiquitin Proteasome Pathway System (UPS).

Artizan Biosciences

Artizan Biosciences is a biotechnology company focused on drug discovery and development for diseases involving the human intestinal microbiota.

Cilatus BioPharma

Cilatus BioPharma specialises in the management and services of CMC Development, CMC Regulatory Affairs, Quality Management, Engineering, Validation/Qualification and Manufacturing for biological products. Cilatus supports small, medium and large biopharma companies in strategy development, strategy execution and operations with our fully integrated team of experienced consultants.

Hatteras Venture Partners (HVP)

Hatteras Venture Partners (HVP) is a life sciences focused venture capital firm based in North Carolina. HVP invests in early stage companies in life sciences with a broad focus including medical devices, diagnostics, discovery science and clinical platforms as well as healthcare IT.

Company website

Recent company news

August 25, 2015

Hatteras Venture Partners Announces First Closing of HVP V

Immunocore

Immunocore is one of the world’s leading biotechnology companies, with a highly innovative immuno-oncology platform technology called ImmTACs (Immune mobilising monoclonal TCRs Against Cancer). ImmTACs are a novel class of biologic drugs based on the Company’s proprietary T cell receptor (TCR) technology, which have the potential to treat diseases with high unmet medical need including cancer, viral infections and autoimmune diseases.

Company website

Recent company news

September 5, 2018

Immunocore strengthens IP position in the field of TCR-based therapeutics

Jaan Health

Jaan Health is a privately held, healthcare mobile technology company. Jaan Health has developed Phamily™ – the first mobile and web based community care coordination platform that leverages family resources intended to change patient behaviour and streamline follow-up.

Company website
KNOW Bio

KNOW Bio is focused on the development of novel nitric oxide based therapies targeting a diverse range of indications.

Recent company news

November 2, 2017

Novoclem Presents Promising New Data At The North America Cystic Fibrosis Conference on November 2, 2017

Kymab

Kymab is a biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary KymouseTM antibody platform.

Company website

Recent company news

November 30, 2018

Kymab granted leave to appeal to the UK Supreme Court

Melinta Therapeutics

Melinta Therapeutics, Inc. is dedicated to saving lives threatened by the global public health crisis of bacterial infections through the development of novel antibiotics that provide new and better therapeutic solutions.

Company website

Recent company news

November 27, 2018

Melinta Therapeutics Granted European Commission Marketing Authorization for Vabomere® (meropenem and vaborbactam)

NeuVT

NeuVT is a global medical company committed to transforming the treatment of stroke and vascular disease by designing, developing and commercialising innovative and effective interventional therapies.

Novan

Novan, Inc. is a late-stage pharmaceutical company focused on redefining the standard of care in dermatology through the development and commercialisation of innovative therapies using the Company’s nitric oxide platform.

Company website

Recent company news

December 11, 2018

Novan to Present Data from SB414 Phase 1b Atopic Dermatitis Clinical Trial at 3rd Inflammatory Skin Disease Summit

Poseida Therapeutics

Poseida is a human therapeutics company focused on the development of novel therapies using its ground-breaking proprietary genome engineering technologies.

Company website

Recent company news

December 4, 2018

Poseida Therapeutics Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Product Candidate at the 2018 American Society of Hematology Annual Meeting

Serenus

Serenus is a specialty biopharmaceutical company, specialising in in-licensing, registering, and commercialising U.S. Food and Drug Administration, European Medicines Agency and Japan’s Pharmaceutical and Medical Devices Agency approved therapeutics to address unmet medical needs with high regional prevalence in the African market.

Company website

Recent company news

November 16, 2015

Serenus Biotherapeutics to Launch Xenex UV Disinfection Robot at IPNET-K Conference 2015 in Naivasha, Kenya

Viamet Pharmaceuticals

Viamet is a drug discovery company focused on the development and commercialisation of novel small molecule drugs that target metalloenzymes via a proprietary platform called Metallophile® Technology.

Company website

Recent company news

September 7, 2018

Mycovia Pharmaceuticals Debuts with Initiation of Phase 3 Clinical Trials for Treatment of Recurrent Vulvovaginal Candidiasis

Wren Therapeutics

Wren Therapeutics is a biopharmaceutical company based in Cambridge (UK), focused on drug discovery and development for protein misfolding diseases, including major neurological and rare disorders.

Xenex Disinfection Services

Xenex aims to become the new standard method for disinfection in healthcare facilities worldwide, eliminating harmful bacteria, viruses and fungi which can cause healthcare associated infections in patients and staff. Xenex’s primary product is a patented Xenon Full Spectrum™ UV disinfection Robot which is used for the advanced disinfection of healthcare and other facilities.

Company website

Recent company news

January 11, 2018

Xenex LightStrike Germ-Zapping Robots Helping Stanford Health Care – ValleyCare Destroy Germs and Bacteria